These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 6261857)
1. Membrane receptors for very low density lipoprotein (VLDL) inhibitor of lymphocyte proliferation. Yi PI; Beck G; Zucker S Blood; 1981 Jun; 57(6):1055-64. PubMed ID: 6261857 [TBL] [Abstract][Full Text] [Related]
2. Rat plasma lipoprotein inhibitors of lymphocyte proliferation: specific membrane receptor for very low density lipoproteins. Yi PI; Beck G; Zucker S Int Arch Allergy Appl Immunol; 1981; 65(1):8-14. PubMed ID: 7216515 [TBL] [Abstract][Full Text] [Related]
3. Immunoregulation by low density lipoproteins in man. Inhibition of mitogen-induced T lymphocyte proliferation by interference with transferrin metabolism. Cuthbert JA; Lipsky PE J Clin Invest; 1984 Apr; 73(4):992-1003. PubMed ID: 6323541 [TBL] [Abstract][Full Text] [Related]
4. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E. Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of lymphocyte proliferation stimulated by lectins and allogeneic cells by normal plasma lipoproteins. Morse JH; Witte LD; Goodman DS J Exp Med; 1977 Dec; 146(6):1791-803. PubMed ID: 200701 [TBL] [Abstract][Full Text] [Related]
6. Rat hematopoietic cell receptors for very low density lipoprotein (VLDL) growth inhibitor. Zucker S; Beck G; Yi P; Lysik RM; DiStefano JF Exp Hematol; 1981 May; 9(5):550-62. PubMed ID: 7238661 [TBL] [Abstract][Full Text] [Related]
7. Identification of a lymphocyte surface receptor for low density lipoprotein inhibitor, an immunoregulatory species of normal human serum low density lipoprotein. Curtiss LK; Edgington TS J Clin Invest; 1978 May; 61(5):1298-308. PubMed ID: 207735 [TBL] [Abstract][Full Text] [Related]
8. Lipoprotein metabolism by rat hepatomas. Studies on the etiology of defective dietary feedback inhibition of cholesterol synthesis. Barnard GF; Erickson SK; Cooper AD J Clin Invest; 1984 Jul; 74(1):173-84. PubMed ID: 6330173 [TBL] [Abstract][Full Text] [Related]
9. Disparities in the interaction of rat and human lipoproteins with cultured rat fibroblasts and smooth muscle cells. Requirements for homology for receptor binding activity. Innerarity TL; Pitas RE; Mahley RW J Biol Chem; 1980 Dec; 255(23):11163-72. PubMed ID: 6254962 [TBL] [Abstract][Full Text] [Related]
10. beta-VLDL and acetylated-LDL binding to pigeon monocyte macrophages. Henson DA; St Clair RW; Lewis JC Atherosclerosis; 1989 Jul; 78(1):47-60. PubMed ID: 2667527 [TBL] [Abstract][Full Text] [Related]
11. Low density lipoprotein receptors bind and mediate cellular catabolism of normal very low density lipoproteins in vitro. Chappell DA; Fry GL; Waknitz MA; Muhonen LE; Pladet MW J Biol Chem; 1993 Dec; 268(34):25487-93. PubMed ID: 8244984 [TBL] [Abstract][Full Text] [Related]
12. Low density lipoprotein-receptor plays a major role in the binding of very low density lipoproteins and their remnants on HepG2 cells. Truong TQ; Falstrault L; Tremblay C; Brissette L Int J Biochem Cell Biol; 1999 Jun; 31(6):695-705. PubMed ID: 10404642 [TBL] [Abstract][Full Text] [Related]
13. Complete down-regulation of low-density-lipoprotein-receptor activity in the human hepatoma cell line Hep G2 by beta-migrating very-low-density lipoprotein and non-lipoprotein cholesterol. Different cellular regulatory pools of cholesterol. Kamps JA; van Berkel TJ Eur J Biochem; 1992 Jun; 206(3):973-8. PubMed ID: 1318843 [TBL] [Abstract][Full Text] [Related]
14. Uptake of canine beta-very low density lipoproteins by mouse peritoneal macrophages is mediated by a low density lipoprotein receptor. Koo C; Wernette-Hammond ME; Innerarity TL J Biol Chem; 1986 Aug; 261(24):11194-201. PubMed ID: 3733751 [TBL] [Abstract][Full Text] [Related]
15. Studies on the binding and degradation of human very-low-density lipoproteins by human hepatoma cell line HepG2. Dashti N; Wolfbauer G Biochim Biophys Acta; 1986 Feb; 875(3):473-86. PubMed ID: 3004589 [TBL] [Abstract][Full Text] [Related]
16. Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase. Mulder M; Lombardi P; Jansen H; van Berkel TJ; Frants RR; Havekes LM J Biol Chem; 1993 May; 268(13):9369-75. PubMed ID: 8387492 [TBL] [Abstract][Full Text] [Related]
17. Characterization and specificity of lipoprotein binding to term human placental membranes. Naoum HG; De Chazal RC; Eaton BM; Contractor SF Biochim Biophys Acta; 1987 Aug; 902(2):193-9. PubMed ID: 3620456 [TBL] [Abstract][Full Text] [Related]
18. Very low density lipoprotein hematopoiesis inhibitor from rat plasma. Zucker S; Lysik RM; Chikkappa G; Glucksman MJ; Gomez-Reino J; DiStefano JF Exp Hematol; 1980 Aug; 8(7):895-905. PubMed ID: 16398021 [TBL] [Abstract][Full Text] [Related]
19. Characterization of LDL and VLDL binding sites on human basophils and mast cells. Virgolini I; Li SR; Yang Q; Koller E; Sperr WR; Leimer M; Angelberger P; Nimpf J; Schneider W; Valent P Arterioscler Thromb Vasc Biol; 1995 Jan; 15(1):17-26. PubMed ID: 7538422 [TBL] [Abstract][Full Text] [Related]
20. Lipoprotein lipase binds to low density lipoprotein receptors and induces receptor-mediated catabolism of very low density lipoproteins in vitro. Medh JD; Bowen SL; Fry GL; Ruben S; Andracki M; Inoue I; Lalouel JM; Strickland DK; Chappell DA J Biol Chem; 1996 Jul; 271(29):17073-80. PubMed ID: 8663292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]